Deborah KletzkySchlossmanMD

Ophthalmology • Boston, MA

Cataract Related, Glaucoma Related, Retinal Disease

Assistant Professor of Ophthalmology, Harvard Medical School

Join to view full profile

Dr. Schlossman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Schlossman's full profile

Already have an account?

Office
1 Joslin Place
Boston, MA 02215
Phone+1 617-309-2554
Is this information wrong?

Summary

Dr. Deborah Kletzky Schlossman is an Assistant Professor of Ophthalmology at Harvard Medical School in Boston, MA. She is affiliated with multiple hospitals in the area including Beth Israel Deaconess Medical Center, Massachusetts Eye and Ear, and Brigham and Women's Hospital. She received her medical degree from Tufts University School of Medicine and has been in practice 29 years. She specializes in cataract surgery and and diabetic retinal disease.

Education & Training

Joslin Diabetes CenterFellowship, Diabetic Eye Disease, 1992 - 1993
MedStar Health/Georgetown-Washington Hospital CenterResidency, Ophthalmology, 1989 - 1992
New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1988 - 1989
Tufts University School of MedicineClass of 1988

Certifications & Licensure

MA State Medical License 1992 - 2025
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Alpha Omega Alpha (AOA) Honor Society 1987
CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema Start of enrollment: 2003 Jul 01
Completed
Phase 2
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) Start of enrollment: 2006 Jun 01
Completed
Phase 2
A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema Start of enrollment: 2004 Dec 01
Completed
Phase 2
The Course of Response to Focal Photocoagulation for DME Start of enrollment: 2007 Jan 01
Completed
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
Completed
Phase 3
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) Start of enrollment: 2011 May 01
Completed
Phase 2
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy Start of enrollment: 2012 Mar 01
Completed
Phase 3
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Start of enrollment: 2012 Aug 01
Completed
Phase 3
Treatment for CI-DME in Eyes With Very Good VA Study Start of enrollment: 2013 Oct 01
Completed
Phase 3
Phase II Combination Steroid and Anti-VEGF for Persistent DME Start of enrollment: 2014 Feb 01
Completed
Phase 2
The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates Start of enrollment: 2015 Aug 01
Completed
Phase 1, Phase 2
Anti-VEGF Treatment for Prevention of PDR/DME Start of enrollment: 2016 Jan 01
Completed
Phase 3
PRP vs Bevacizumab for PDR Treatment Start of enrollment: 2016 Feb 01
Completed
Phase 2, Phase 3
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR Start of enrollment: 2016 Nov 01
Completed
Phase 2, Phase 3
DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME Start of enrollment: 2017 Dec 07
Completed
Phase 3
PROMINENT-Eye Ancillary Study (Protocol AD) Start of enrollment: 2018 Jan 15
Terminated
Phase 3
Effects of Pneumatic Vitreolysis on Vitreomacular Traction Start of enrollment: 2018 Oct 16
Completed
Phase 3
Effects of Pneumatic Vitreolysis on Macular Hole Start of enrollment: 2018 Nov 14
Completed
Not Applicable
A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema Start of enrollment: 2019 Apr 10
Completed
Not Applicable
Fenofibrate for Prevention of DR Worsening Start of enrollment: 2021 Mar 05
Recruiting
Phase 3
Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy Start of enrollment: 2021 Mar 30
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

Have Electronic Health Records Improved the Quality of Patient Care?
Krenn L, Schlossman D> ;PM & R : the journal of injury, function, and rehabilitation.
15 citations
Optical Coherence Tomography Angiography Quality Across Three Multicenter Clinical Studies of Diabetic Retinopathy.
Brandon J. Lujan, Claire T. Calhoun, Adam R. Glassman, Joseph M. Googe, Lee M. Jampol, Michele Melia, Deborah K. Schlossman, Jennifer K. Sun> ;Translational Vision Science & Technology. 2021 Mar 1
Serum urate and cardiovascular events in the DCCT/EDIC study.
Jenkins AJ, Braffett BH, Basu A, Bebu I, Dagogo-Jack S, Orchard TJ, Wallia A, Lopes-Virella MF, Garvey WT, Lachin JM, Lyons TJ, DCCT/EDIC Research Group> ;Scientific reports. 2021-07-09
24 citations
DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes.
Delnaz Roshandel, Zhuo Chen, Angelo J. Canty, Shelley B. Bull, Rama Natarajan, Andrew D. Paterson, Stephen W. Scherer, F. Miao, L. Zhang, J. Brown-Friday, Jill P. Cran...> ;Clinical Epigenetics. 2020 Apr 5
Evolving strategies in the management of diabetic macular edema: clinical trials and current management.
Thomas BJ, Shienbaum G, Boyer DS, Flynn HW> ;Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T.
Wykoff CC, Hariprasad SM> ;Ophthalmic surgery, lasers & imaging retina.
Advances in the management of diabetic macular oedema based on evidence from the Diabetic Retinopathy Clinical Research Network.
Lim LT, Chia SN, Ah-Kee EY, Chew N, Gupta M> ;Singapore medical journal.
Diabetic Macular Edema: Options for Adjunct Therapy.
Calvo P, Abadia B, Ferreras A, Ruiz-Moreno O, Verdes G, Pablo LE> ;Drugs.
[Aflibercept in the Diabetic Macular Edema Treatment].
Studnička J> ;Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti.
Evaluating Effects of Switching Anti-Vascular Endothelial Growth Factor Drugs for Age-Related Macular Degeneration and Diabetic Macular Edema.
Ferris FL, Maguire MG, Glassman AR, Ying GS, Martin DF> ;JAMA ophthalmology.
The Early Treatment Diabetic Retinopathy Study historical review and relevance to today's management of diabetic macular edema.
Relhan N, Flynn HW> ;Current opinion in ophthalmology.
Setting Priorities for Diabetic Retinopathy Clinical Research and Identifying Evidence Gaps.
Le JT, Hutfless S, Li T, Bressler NM, Heyward J, Bittner AK, Glassman A, Dickersin K> ;Ophthalmology. Retina.
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T.
Cai S, Bressler NM> ;Current opinion in ophthalmology.
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
Maturi RK, Glassman AR, Liu D, Beck RW, Bhavsar AR, Bressler NM, Jampol LM, Melia M, Punjabi OS, Salehi-Had H, Sun JK, Diabetic Retinopathy Clinical Research Network> ;JAMA ophthalmology.
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Se...
Bressler NM, Beaulieu WT, Glassman AR, Blinder KJ, Bressler SB, Jampol LM, Melia M, Wells JA, Diabetic Retinopathy Clinical Research Network> ;JAMA ophthalmology.
Diabetic Macular Edema: Current Understanding, Pharmacologic Treatment Options, and Developing Therapies.
Miller K, Fortun JA> ;Asia-Pacific journal of ophthalmology (Philadelphia, Pa.).
Recent clinically relevant highlights from the Diabetic Retinopathy Clinical Research Network.
Krick TW, Bressler NM> ;Current opinion in ophthalmology.
Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Ed...
Glassman AR, Liu D, Jampol LM, Sun JK, Diabetic Retinopathy Clinical Research Network> ;Investigative ophthalmology & visual science.
Visual Acuity Outcomes in Diabetic Macular Edema With Fluocinolone Acetonide 0.2 μg/Day Versus Ranibizumab Plus Deferred Laser (DRCR Protocol I).
Singer MA, Miller DM, Gross JG, Greven CM, Kapik B, Bailey C, Ghanchi F, Kuppermann BD> ;Ophthalmic surgery, lasers & imaging retina.
CHANGES IN DIABETIC RETINOPATHY SEVERITY WHEN TREATING DIABETIC MACULAR EDEMA WITH RANIBIZUMAB: DRCR.net Protocol I 5-Year Report.
Bressler SB, Odia I, Glassman AR, Danis RP, Grover S, Hampton GR, Jampol LM, Maguire MG, Melia M> ;Retina (Philadelphia, Pa.).
Nine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive error.
Cheng CY, Schache M, Ikram MK, Young TL, Guggenheim JA, Vitart V, MacGregor S, Verhoeven VJ, Barathi VA, Liao J, Hysi PG, Bailey-Wilson JE, St Pourcain B, Kemp JP, McM...> ;American journal of human genetics.
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun J...> ;JAMA ophthalmology.
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
DCCT/EDIC Research Group, Nathan DM, Bebu I, Hainsworth D, Klein R, Tamborlane W, Lorenzi G, Gubitosi-Klug R, Lachin JM> ;The New England journal of medicine.
Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Inter...
Purnell JQ, Braffett BH, Zinman B, Gubitosi-Klug RA, Sivitz W, Bantle JP, Ziegler G, Cleary PA, Brunzell JD, DCCT/EDIC Research Group> ;Diabetes care.
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center o...
Baker CW, Glassman AR, Beaulieu WT, Antoszyk AN, Browning DJ, Chalam KV, Grover S, Jampol LM, Jhaveri CD, Melia M, Stockdale CR, Martin DF, Sun JK, DRCR Retina Network> ;JAMA. 2019-04-29
Join now to see all

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow

Hospital Affiliations

Beth Israel Deaconess Medical CenterBoston, Massachusetts
Massachusetts Eye and EarBoston, Massachusetts

External Links

Joslin https://eye.hms.harvard.edu/deborahschlossman
Paintingshttps://www.deborahschlossman.com/
Instagramhttps://www.instagram.com/dschlossman